• 10 Hits
  • 検索条件 : 絞込み (MeSH = Adenocarcinoma of Lung / drug therapy*)
生物種 リソース名 タイトル
ヒト・動物細胞 A549(RCB0098) Upregulation of Chemoresistance by Mg2+ Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells.
ヒト・動物細胞 LU99(RCB1900) , LU65(RCB1967) , IA-LM(RCB0554) The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
ヒト・動物細胞 PC-9(RCB4455) Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma.
ヒト・動物細胞 A549, LC-2/ad(RCB0440) TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.
ヒト・動物細胞 PC-9(RCB4455) Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells.
ヒト・動物細胞 RERF-LC-AI(RCB0444) Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells.
遺伝子材料 pENTR4-H1 (RDB04395) , CS-RfA-CG (RDB04390) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification.
ヒト・動物細胞 PC-9(RCB4455) AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
ヒト・動物細胞 TE-4(RCB2097) Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation.
遺伝子材料 pENTR4-H1 (RDB04395) , CS-RfA-EG (RDB04391) , CSII-CMV-RfA-IRES2-Venus (RDB04388) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394). CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.